IMS 2023 | Elucidating the earliest genomic events in multiple myeloma
Anthony Cirrincione
• 27 Sep 2023
Anthony Cirrincione, PhD, Sylvester Comprehensive Cancer Center, Miami, FL, provides an overview of recent efforts to characterize the genomic origins of multiple myeloma. Despite knowledge of current genomic alterations such as hyperdiploidy and IgH translocations, finding genomic events that precede known alterations will help better understand the pathogenesis of multiple myeloma. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
